§ PHARMACEUTICALS
USD · Pharmaceuticals

INVA

INNOVIVA INC
USDSector · PharmaceuticalsBeta · 0.44
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
183 increased/new, 86 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E6.6P/B1.27
EPS (TTM)2.99
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.11.3M0.0%+6%
Dimensional Fund Advisors4.4M0.0%+2%
VANGUARD PORTFOLIO MANAGEMENT LLC4.2Mn/an/a
Renaissance Technologies4.1M0.1%−4%
VANGUARD CAPITAL MANAGEMENT LLC3.1Mn/an/a
State Street3.1M0.0%+9%
◇ AC INTELLIGENCE

Top institutional owners for INVA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER95.2% · 0 holders
OTHER1.7% · 190 holders
PASSIVE / INDEX0.9% · 11 holders
DEALER / BANK0.7% · 27 holders
SYSTEMATIC / QUANT0.6% · 10 holders
QUALITY / COMPOUNDER0.6% · 19 holders
TACTICAL / MACRO0.2% · 3 holders
DEEP VALUE0.1% · 1 holder
INCOME / DEFENSIVE0.1% · 26 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for INVA in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES